-
Revenue
$-2.54M
Net Income
-
Gross Margin
-
Op. Margin
$-3.54M
Free Cash Flow
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|---|
| Total Revenue | - | - | - | - | - | $2.57K |
| Revenue Growth % | nan% | nan% | nan% | nan% | nan% | nan% |
| Operating Expenses | $2.22M | $2.22M | $5.22M | $4.38M | $1.69M | $172.87K |
| Research & Development | $815.90K | $815.90K | $1.54M | $1.00M | $850.68K | - |
| Operating Income | $-2.22M | $-2.22M | $-5.22M | $-4.38M | $-1.69M | $-170.30K |
| Operating Margin % | nan% | nan% | nan% | nan% | nan% | -6631.7% |
| Interest Expense | - | - | - | - | $14.00 | $207.00 |
| Other Income/Expense | $-41.48K | $-41.48K | $-31.99K | $90.15K | $1.74K | $-207.00 |
| Income Before Tax | $-2.54M | $-2.54M | $-5.78M | $-3.57M | $-1.68M | $-170.51K |
| Net Income | $-2.54M | $-2.54M | $-5.78M | $-3.57M | $-1.68M | $-170.51K |
| Net Margin % | nan% | nan% | nan% | nan% | nan% | -6639.8% |
| Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 | 0.00 |
| Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 | 0.00 |
| Basic Shares Outstanding | - | 957.0M | 672.5M | 296.7M | 437.7M | 202.3M |
| Diluted Shares Outstanding | - | 957.0M | 672.5M | 296.7M | 437.7M | 202.3M |
| Breakdown | FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|
| Cash & Cash Equivalents | $228.54K | $549.44K | $3.35M | $1.04M | $185.94K |
| Accounts Receivable | - | - | - | - | $1.36K |
| Other Current Assets | $1.55K | $1.26K | $114.10K | - | - |
| Total Current Assets | $238.77K | $638.58K | $3.46M | $1.14M | $192.36K |
| Property Plant & Equipment | $20.16K | $24.14K | $2.33K | $3.00K | - |
| Total Assets | $258.94K | $662.73K | $3.46M | $1.14M | $192.36K |
| Accounts Payable | $113.58K | $215.36K | $106.83K | $30.79K | - |
| Total Current Liabilities | $2.96M | $906.74K | $297.10K | $546.92K | $737.47K |
| Other Non-current Liabilities | $176.09K | $123.98K | $5.24K | - | - |
| Total Liabilities | $3.13M | $1.03M | $302.35K | $547.33K | $737.47K |
| Common Stock | $95.70K | $95.70K | $49.55K | $43.77K | $20.23K |
| Retained Earnings | $-22.05M | $-19.51M | $-13.73M | $-10.16M | $-41.62M |
| Total Stockholders Equity | $-2.87M | $-367.99K | $3.16M | $596.08K | $2.26M |
| Total Liabilities & Equity | $258.94K | $662.73K | $3.46M | $1.14M | $192.36K |
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|---|
| Net Income | $-2.54M | $-2.54M | $-5.78M | $-3.57M | $-1.68M | $-170.51K |
| Stock-based Compensation | - | $39.17K | $2.25M | $2.25M | $19.91K | - |
| Change in Receivables | - | - | - | - | - | $1.36K |
| Change in Payables | $94.31K | $-128.58K | $112.55K | $44.11K | - | - |
| Operating Cash Flow | $-3.54M | $-2.06M | $-2.74M | $-2.36M | $-1.52M | $-136.10K |
| Capital Expenditure | - | $966.00 | $25.85K | - | - | - |
| Investing Cash Flow | - | $-966.00 | $-25.85K | $17.97K | - | - |
| Financing Cash Flow | $2.55M | $1.75M | - | $4.65M | - | - |
| Net Change in Cash | $-1.01M | $-320.90K | $-2.80M | $2.31M | $-1.52M | - |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Operating Expenses | $469.88K | - | $1.78M | - |
| Research & Development | $151.46K | - | $715.13K | - |
| Operating Income | $-469.88K | - | $-1.78M | - |
| Other Income/Expense | $-16.40K | - | $-31.20K | - |
| Income Before Tax | $-653.53K | - | $-1.99M | - |
| Income Tax Expense | - | - | - | - |
| Net Income | $-653.53K | $-1.51M | $-1.99M | - |
| Basic EPS | 0.00 | - | 0.00 | - |
| Diluted EPS | 0.00 | - | 0.00 | - |
| Basic Shares Outstanding | $957.00M | - | $957.00M | - |
| Diluted Shares Outstanding | $957.00M | - | $957.00M | - |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Other Current Assets | $10.42K | $89.14K |
| Total Current Assets | $250.78K | $638.58K |
| Property Plant & Equipment | $20.44K | $24.14K |
| Total Assets | $271.22K | $662.73K |
| Accounts Payable | $447.25K | $215.36K |
| Total Current Liabilities | $2.42M | $906.74K |
| Other Non-current Liabilities | $168.55K | $123.98K |
| Total Liabilities | $2.59M | $1.03M |
| Common Stock | $95.70K | $95.70K |
| Retained Earnings | $-21.50M | $-19.51M |
| Total Stockholders Equity | $-2.32M | $-367.99K |
| Total Liabilities & Equity | $271.22K | $662.73K |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $-653.53K | $-1.51M | $-1.99M | - |
| Stock-based Compensation | - | - | $39.17K | - |
| Change in Payables | - | - | $231.89K | - |
| Operating Cash Flow | - | - | $-1.41M | - |
| Capital Expenditure | - | - | - | - |
| Investing Cash Flow | - | - | - | - |
| Financing Cash Flow | - | - | $1.10M | - |
| Net Change in Cash | - | - | $-309.08K | - |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.
Annual data represents full fiscal year results. FY = Fiscal Year ending.